Market Tracker

04/23 6:05pm ET

Dyax Corp (NASDAQ:DYAX)

6.84
Data as of Apr 23
 -0.43 / -5.91%
Today’s Change
2.26
Today|||52-Week Range
10.99
-9.22%
Year-to-Date

Today’s Trading

Previous close7.27
Today’s open7.10
Day’s range6.75 - 7.26
Volume1,674,793
Average volume (3 months)1,656,199
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)+13.33%
Earnings growth (this year)+15.93%
Earnings growth (next 5 years)+8.37%
Revenue growth (last year)-1.32%
P/E ratioNM
Price/Sales15.17
Price/Book36.71

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo BioSciences ...-0.64-4.37%
IDIXIdenix Pharmaceutica...-0.41-6.90%
KERXKeryx Biopharmaceuti...-0.44-3.09%
LXRXLexicon Pharmaceutic...-0.15-8.57%
Data as of 3:59pm ET, 04/23/2014

Financials

Next reporting dateApril 30, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$53.9M
Annual profit (last year)-$27.8M
Net profit margin-51.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gustav A. Christensen
Chief Financial Officer &
Executive Vice President
George V. Migausky
Corporate headquarters
Burlington, Massachusetts

Forecasts